US20060093669A1 - Calcium hypochlorite blended tablets - Google Patents

Calcium hypochlorite blended tablets Download PDF

Info

Publication number
US20060093669A1
US20060093669A1 US11314512 US31451205A US2006093669A1 US 20060093669 A1 US20060093669 A1 US 20060093669A1 US 11314512 US11314512 US 11314512 US 31451205 A US31451205 A US 31451205A US 2006093669 A1 US2006093669 A1 US 2006093669A1
Authority
US
Grant status
Application
Patent type
Prior art keywords
tablet
weight
calcium hypochlorite
magnesium sulfate
less
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11314512
Inventor
James Brennan
Paul Loomis
Original Assignee
Brennan James P
Loomis Paul S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01BNON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B11/00Oxides or oxyacids of halogens; Salts thereof
    • C01B11/04Hypochlorous acid
    • C01B11/06Hypochlorites

Abstract

A non-Division 5.1 Oxidizer tablet consisting essentially of a blend of hydrated calcium hypochlorite with magnesium sulfate heptahydrate, wherein the blend contains at least about 17% by weight of water based on the total weight of the blend; contains from about 0.1% to about 10% of lime based on the total weight of the hydrated calcium hypochlorite and magnesium sulfate heptahydrate and the average dissolving rate of the tablet is less than 150 grams per day.

Description

    CROSS REFERENCE TO RELATED APPLICATION
  • This application is a continuation of U.S. patent application Ser. No. 10/405,388 entitled “CALCIUM HYPOCHLORITE BLENDED TABLETS” file on Apr. 2, 2003. That parent application is incorporated by reference in its entirety.
  • BACKGROUND OF THE INVENTION
  • 1. Field of the Invention
  • The present invention relates to tablets having diminished fire producing properties and is a slow dissolving product containing selected mixtures of hydrated calcium hypochlorite with magnesium sulfate heptahydrate.
  • 2. Brief Description of Art
  • Hydrated calcium hypochlorite is a strong oxidizer and as such can cause a severe increase in the burning rate of combustible material with which it comes in contact. This oxidation characteristic can cause problems both in the transport and storage of the product. For example, fires involving calcium hypochlorite can be quite vigorous, particularly when combustible material is present, including the product's packaging material itself (e.g., plastic, cardboard). The blends of hydrated calcium hypochlorite and magnesium sulfate heptahydrate of the invention are not classified as a “Division 5.1 Oxidizer” (i.e. they do not increase the burning rate of combustible material) as measured by an internationally recognized test standard, i.e., the United Nations Protocol: Transport of Dangerous Goods: Manual of Tests and Criteria, Section 34; Classification Procedures, Test Methods, and Criteria relating to Oxidizing Substances of Division 5.1.
  • Products that are “Division 5.1 Oxidizers” are by definition “dangerous goods” for purposes of transport. The following references have discussed this fire-causing problem and offered solutions to it.
  • U.S. Pat. No. 3,793,216 (Feb. 19, 1974) (assigned to Pennwalt) teaches adding water in the form of a hydrated inorganic salt to anhydrous calcium hypochlorite (less than 1% water) so that the total resulting water in the blend was from 3 to 13% resulting in a product that “provides resistance to exothermic, self-propagating decomposition when contacted by flame, spark, or a contaminating organic substance”. The test used in this patent to verify this property was an “ignition test”, which contacts the test sample (from 10 to 500 grams) with a lit match, or a drop of glycerin or 2-propanol. Ignition and self-propagation of burning are indicators of failure. Blends that have a delayed reaction, a less vigorous reaction, or a localized reaction compared to anhydrous calcium hypochlorite were considered to be successful blends. However, this “ignition test” is not a demanding test. Since no fuel is present the procedure does not test the oxidizing properties, i.e., they could still increase the burning rate of combustible materials. In fact, as will be shown below, many blend products described by this Pennwalt patent pass this ignition test but would still be classified as “Division 5.1 Oxidizers”.
  • U.S. Pat. No. 4,201,756 (May 6, 1980), (assigned to Olin) teaches the coating of calcium hypochlorite with a plurality of layers of inorganic salts. The first layer must be comprised of salts of Periodic Table Group I alkali metal salts (sodium, potassium, lithium, rubidium, cesium or francium.) The salt must be a chloride, chlorate, nitrate, bromide, bromate, or sulfate. The first layer forms a barrier so that incompatible salts such as basic aluminum sulfate, alkalized magnesium sulfate, and sodium borates may be coated with a second layer on the pre-coated calcium hypochlorite without physical contact with the calcium hypochlorite. See column 17, lines 36 to 54. The layers of salt form a physical barrier, which resists dusting and degradation during handling, and also decreases propensity for ignition and self-sustained decomposition when contacted by a lighted match or incompatible organic materials.
  • There are many differences between this Olin patent and the present invention. First, the requirement that an inert alkaline salt (such as sodium chloride) be added as a barrier between calcium hypochlorite and a material such as magnesium sulfate heptahydrate is not necessary. Second, the requirement that the final water content of the coated calcium hypochlorite be between 0.5 and 10% is actually counter-productive for reducing the oxidizing behavior of calcium hypochlorite. As such, the mechanism is different from that disclosed in this invention, which involves physically mixing the two substances so that they are in physical contact with each other, and maintaining a water content of at least 17%.
  • The best indicator of the difference between the two ideas is shown using Example XIV in the Olin patent. The example shows that calcium hypochlorite encapsulated with sodium chloride (approximately 21% by weight) prevented ignition of the material when contacted with a lighted match, i.e., it failed to undergo self-sustained decomposition. Our experiments show that physically blending 21% sodium chloride with calcium hypochlorite actually accelerates burning. As stated above, the mechanism is therefore different.
  • In addition, calcium hypochlorite tablets have demonstrated very fast dissolving rates in water. For example, as shown in U.S. Pat. Nos. 4,876,003 and 4,928,813 (both issued to Casburg and were assigned to Olin), plastic sleeves were positioned around the tablet to slow down the dissolving rate of calcium hypochlorite tablets. When placed around the tablets, the tablets last longer, thus providing convenience in chlorinating swimming pools and other applications. However, such plastic sleeves after use, must be removed from the skimmers, feeders and floaters for the swimming pools where they were used. This removal and discarding can be inconvenient to the pool owner. Alternatively, finely divided polyfluorinated polymer has been added to calcium hypochlorite tablets to cause the tablets to dissolve slower. See U.S. Pat. Nos. 4,970,020 and 5,205,961. Other chemical blends for making calcium hypochlorite tables are disclosed in U.S. Pat. Nos. 4,145,306; 4,192,763; 4,692,335; 4,865,760; 4,961,872; 5,009,806; 5,164,109; and 5,753,602
  • There is still a need in this art to produce blended calcium hypochlorite tabletted products that are (1) relatively slow dissolving product that does not require the use of a plastic sleeve or insoluble material and (2) is not classified as a Division 5.1 Oxidizer and which has enhanced safety. (i.e., diminished fire-producing properties). The present invention provides a solution to that need.
  • BRIEF SUMMARY OF THE INVENTION
  • Therefore, one aspect of the present invention is directed to a non-Division 5.1 Oxidizer tablet consisting essentially of a blend of hydrated calcium hypochlorite and magnesium sulfate heptahydrate, wherein the water content of the blend is at least about 17% by weight of the blend and the average dissolving rate of the tablet is less than 150 grams per day.
  • The tablet of the present invention is not a Division 5.1 Oxidizer and will produce fires of dramatically diminished intensity compared to the above-noted prior art calcium hypochlorite-containing blends. Because the products of the present invention are not classified as Division 5.1 Oxidizers, they are not considered dangerous goods for purposes of transport and thus their transportation costs are lower than the above-noted prior art blends.
  • Also due to the dramatically reduced intensity of any fire involving these tablets (compared to currently marketed calcium hypochlorite dihydrate tabletted products) the public good is served by the greatly enhanced safety in the storage and transportation of the product.
  • DETAILED DESCRIPTION OF THE INVENTION
  • The term “non-Division 5.1 Oxidizer composition” as used in the present specification and claims refers to any blend of calcium hypochlorite hydrate and magnesium sulfate heptahydrate that is not classified as a UN Division 5.1 Oxidizer according to standard testing procedures now in effect.
  • The term “tablet” is used in the present specification and claims to cover any shape or size tablet, or other compressed shaped product made of a blend of the two critical materials. Such tablets do not cover loose granular materials such as covered by copending U.S. patent application Ser. No. 10/271,375 filed on Oct. 15, 2002. Such tablets may be made according to any conventional tablet-making process and/or any conventional equipment that is used for making pool sanitizer tablets.
  • The term “blend” is used in the present specification and claims refer to any homogeneous or near homogeneous mixture of the two critical materials. It does not include encapsulated or layered products such as covered in U.S. Pat. No. 4,201,756.
  • The term “hydrated” as used in conjunction with calcium hypochlorite products in the present specification and claims refers to any calcium hypochlorite product that has a water content of at least 5% by weight of calcium hypochlorite product. Preferably, the compositions of the present invention consist of commercial “hydrated” (5.5% to 16% water) calcium hypochlorite, CAS number [7778-54-3] and magnesium sulfate heptahydrate, CAS number [10034-99-8]. These preferred blends do not accelerate burning and are therefore non-oxidizers (as measured by the industry standard oxidizer classification test, i.e., United Nations Protocol Transport of Dangerous Goods—Oxidizing Substances of Division 5.1).
  • The term “average dissolving rate” as used in the present invention, unless otherwise identified, is used to mean the static average dissolving rate of the tabletted blends of the present invention in a standing volume of water.
  • As stated above, the tablets of the present invention have an average dissolving rate of less than about 150 grams/day. In other words, a 300 gram tablet will take at least 2 days to dissolve completely in a standing (non-flowing) body of water. Preferably, the average dissolving rate is less than 100 grams per day for the tablets of the present invention. It should be recognized that the average dissolving rate of the tabletted blends of the present invention will generally have higher dissolving rates in flowing water conditions such as in a skimmer or a feeder in a swimming pool.
  • The composition preferably contains at least about 25% by weight of magnesium sulfate heptahydrate and less than about 75% by weight of hydrated calcium hypochlorite. More preferably, these compositions contain from about 25% to about 40% magnesium sulfate heptahydrate and about 60% to about 75% by weight of hydrated calcium hypochlorite.
  • Also, the amount of water in the blend should be at least about 17% by weight of the total blend; more preferably, about 18% to about 24% by weight of the blend. The granular magnesium sulfate heptahydrate is physically blended with granular calcium hypochlorite to produce an essentially homogeneous granular mixture. As stated above, the blends are not classified as UN Division 5.1 oxidizers.
  • The tabletted composition of the present invention may also contain small amounts of other materials as long as the presence of those materials does not cause the resulting product to be classified as a Division 5.1 Oxidizer.
  • One preferred material is lime (Ca(OH)2) which may be included in amounts up to about 3% by weight; more preferably, from 0.1% to about 2% by weight of the total blend of the two critical ingredients.
  • The amount of water in the tabletted product may be calculated by any standard analytical method for measuring water in chemical products like these. Our preferred method is thermogravimetric analysis (TGA).
  • The tabletted products of the present invention may be made from granular blends of the two critical ingredients (with or without optional additives such as lime) according to any conventional tabletting process and equipment normally used for making calcium hypochlorite hydrate-containing tablets. Any suitable equipment that produces molded compacted products such as tablets, caplets or briquettes, or other known molded compacted products, using the blends of the present invention may be used. Any shape or size tablet may be used. One preferred form of tablet is shown in U.S. Pat. No. 4,876,003. The preferred size tablet of that cylindrical shape is about 4 inches in length and about 1 inch in diameter. Preferred tabletting equipment includes hydraulic presses (such as Hydratron or Bipel hydraulic press). Any suitable dwell times and pressures may be used in operating such hydraulic presses. Specifically, these tablets are useful as water treatment sanitizers (e.g. in swimming pools and spas), and are especially safer to transport and store than calcium hypochlorite itself.
  • While not a preferred embodiment, it may be useful for some applications to place a plastic sleeve over the tabletted blends of the present invention to obtain a tabletted product that has even longer dissolving times.
  • The present invention is further described in detail by means of the following Examples and Comparisons. All parts and percentages are by weight and all temperatures are degrees Celsius unless explicitly stated otherwise.
  • EXAMPLES
  • The test for oxidizing substances described in Section 34 of the United Nations Protocol was used to determine the characteristics of the various blends listed in the table below. This test is much more demanding than the glycerin “ignition” test (described earlier), requiring the presence of a substantial amount, i.e., up to 50% by weight, of a fuel (cellulose) rather than one drop of potential fuel. The detailed test method is described in the United Nations Recommendations on the Transport of Dangerous Goods; Manual of Tests and Criteria; Third Revised Edition; Section 34 “Classification Procedures, Test Methods and Criteria Relating to Oxidizing Substances of Division 5.1. In the test, the relative burning rates of the various calcium hypochlorite products are compared to those of other known oxidizers. On the basis of this test, a product can be defined as an oxidizer or a non-oxidizer. The test method states that “This test method is designed to measure the potential for a solid substance to increase the burning rate or burning intensity of a combustible substance when the two are thoroughly mixed. Tests are conducted on the substance to be evaluated mixed with dry fibrous cellulose in mixing ratios of 1:1 and 4:1, by mass, of sample to cellulose. The burning characteristics of the mixtures are compared with the standard 3:7 mixture, by mass, of potassium bromate to cellulose. If the burning time is equal to or less than this standard mixture, the burning times should be compared with those from packing group I or II reference standards, 3:2 and 2:3, by mass of potassium bromate to cellulose respectively.”
  • By definition, a substance that is not Division 5.1 Oxidizer (i.e., not an oxidizing substance) is any substance which, in both the 4:1 and 1:1 sample-to-cellulose ratio (by mass) tested, does not ignite and burn, or exhibits mean burning times greater than that of a 3:7 mixture (by mass) of potassium bromate and cellulose.
  • The following blends of both hydrated and anhydrous calcium hypochlorite with other materials were evaluated using the test method discussed above.
    TABLE 1
    Testing results of various calcium hypochlorite (anhydrous and
    hydrated) blends using the UN Division 5.1 oxidizer classification test.
    Exam- % H20 in 5.1
    ple Blend Components Ratio blend Oxidizer
    Blends with “anhydrous” Ca(OCl)2
    1 Ca(OCl)2/CaSO4.2H2O 80/20 5.0 Yes
    2 Ca(OCl)2/Na2B4O7.5H2O 80/20 7.0 Yes
    3 Ca(OCl)2/Na3PO4.12H2O 85/15 9.5 Yes
    4 Ca(OCl)2/MgSO4.7H2O 90/10 6.0 Yes
    5 Ca(OCl)2/MgSO4.7H2O 75/25 13.5 Yes
    6 Ca(OCl)2/MgSO4.7H2O 70/30 16.0 Yes
    Blends with “hydrated” Ca(OCl)2
    7 Ca(OCl)2.2H2O/CaSO4.2H2O 80/20 9.0 Yes
    8 Ca(OCl)2.2H2O/Na2B4O7.5H2O 80/20 11.0 Yes
    9 Ca(OCl)2.2H2O/Na3PO4.12H2O 85/15 13.8 Yes
    10 Ca(OCl)2.2H2O/MgSO4.7H2O 90/10 10.5 Yes
    11 Ca(OCl)2.2H2O/MgSO4.7H2O 75/25 17.3 No
    12 Ca(OCl)2.2H2O/MgSO4.7H2O 70/30 20.5 No
  • Note that the tests were run both with anhydrous (less than 1% water) and hydrated (6% water) calcium hypochlorite, although it should be noted that hydrated calcium hypochlorite did not exist on a commercial basis when the earlier Pennwalt work was done.
  • The tests show that the first four blends in the table (Examples 1-4), while they are within the scope of the Pennwalt patent, do not pass the UN Division 5.1 Oxidizer test. All are classified as oxidizers by that test.
  • The only blends that pass the UN Division 5.1 Oxidizer (i.e., are not oxidizers) are the 75/25 and 70/30 hydrated cal hypo/MgSO4.7H2O blends (Examples 11 and 12). Note that neither the 75/25 nor the 70/30 anhydrous calcium hypochlorite/MgSO4.7H2O blends (Examples 5 and 6) pass the UN Division 5.1 Oxidizer test. Both the 75/25 and 70/30 hydrated cal hypo/MgSO4.7H2O blends are outside of the scope of the Pennwalt patent for at least two reasons. First, as stated earlier, hydrated calcium hypochlorite did not exist commercially at that time, and, second, the products both contain substantially more than 13% water cited in the Pennwalt patent.
  • Further testing also showed that the 70/30 blend of hydrated calcium hypochlorite and magnesium sulfate heptahydrate did not accelerate the burning of the product in 5-lb. plastic bottles. The bottles containing the blends of Examples 11 and 12, when artificially set on fire using kerosene and a torch burned slowly, showing a burn rate similar to the empty plastic packages themselves. Conversely, calcium hypochlorite hydrate alone in the same quantity and packaging, burned quite vigorously.
  • Continuous Flow Tabletting Dissolving Test
  • Six formulations noted below in Table 2 were prepared by first homogenously blending the listed ingredients together for each formulation and then preparing six batches of tablets of such blends that weighed 285 grams each. These tablets were produced on either Bipel or Hydratron hydraulic tabletting machine into a shape similar to the cylindrical tablets shown in U.S. Pat. No. 4,876,003 (Casberg et al.). The Bipel press was a 3-tablet, 70 ton Split Preformer Bipel Hydraulic Press. The batches made with it had dwell times between 2.4 and 3.0 seconds and the pressures were 2800-3100 psig. The Hydratron Press was a 30 ton, Single Tablet, Hydratron Hydraulic Press. The batches made with it were run at 0.6 second dwell and a pressure of 2100-2200 psig.
    TABLE 2
    Calcium Hypochlorite Hydrate/Magnesium Sulfate Heptahydrate/Lime
    Formulations
    Formulation Ca(OCl)2.2H20 MgSO4.7H20 Ca(OH)2
    1 70 30 0
    2 30 27 3
    3 70 28.5 1.5
    4 70 29 1
    C-5  98.5 0 1.5
    C-6* 98.5 0 1.5

    *Formulation had a plastic sleeve around the tablet as shown in U.S. Pat. No. 4,876,003.
  • These tablets of such formulation were then placed in separate skimmers in a swimming pool. The flow rate of water through the skimmers was 30 gallons per minute. The size basket of the skimmer was 6.5 inches. The test was run with the water flow on for 12 continuous hours and then off for 12 continuous hours for each day. During the off period, the tablets were submerged under water in the skimmer. These tablets were removed from the skimmers at periodic time intervals and weighed. The approximate average dissolving rates of each formulation over a 2 to 6-day test period are shown below in Table 3.
    TABLE 3
    Average Dissolving
    Formulation Rates (grams/day)
    1 137
    2 73
    3 94
    4 73
    5 790
    6 118
  • Static Dissolving Tests
  • Four formulations noted below in Table 4 were prepared by first homogenously blending the listed ingredients together for each formulation and then preparing tablets of such blends. Each tablet weighed 285 grams. These tablets were produced on a hydraulic tabletting machine all from batches about 200 pounds each into a shape similar to the cylindrical tablets shown in U.S. Pat. No. 4,876,003 (Casberg et al.). These tablets were all produced on the 30 ton, Single Tablet, Hydratron Hydraulic Press. The pressing pressure for all batches was 2500 to 2800 psig with a 0.2 second dwell.
    TABLE 4
    Formulation Ca(OCl)2.2H20 MgSO4.7H20 Ca(OH)2
    1 98.5%   1.5%
    2 70% 30%
    3 70% 28.5%   1.5%
    4 70% 27%   3%
  • Each pre-weighted tablet was placed in a basket in 3 liters of water. There was no stirring of the water for 5½ hours. The tablet was removed and re-weighed, then the water was mixed vigorously for 30 minutes before being analyzed for Cl2 content. The water was allowed to settle and the tablets were placed back in their baskets until next time for measurement. The mixing and analyzing procedures were repeated. The results of these measurements are shown in Table 5 below.
    TABLE 5
    g C12 Dosage into pool Dosage per
    Weight % AvC12 in solution per Capsule, (?) Capsule (?) per
    Formulation Time Hours Weight g. Loss Temp. ° C. in solution (by analysis) ppm avcl day, ppm avcl
    Treated Water Used
    #1 0 296.96 0.00 20.0 0.00 0.00
    5.5 225.11 71.85 20.0 2.15 64.50 1.1 4.9
    24 147.24 149.72 20.0 3.69 110.80 1.9 1.9
    48 64.07 232.89 20.0 4.79 144.00 2.5 1.3
    72 28.80 268.16 20.0 4.89 147.00 2.6 0.9
    #2 0 280.52 0.00 20.0 0.00 0.00
    5.5 260.03 20.49 20.0 0.88 26.50 0.5 2.0
    24 241.93 38.59 20.0 1.48 44.33 0.8 0.8
    48 102.67 177.85 20.0 1.69 50.70 0.9 0.4
    72 0.00 280.52 20.0 2.06 61.75 1.1 0.4
    #3 0 298.76 0.00 20.0 0.00 0.00
    5.5 304.98 0.00 20.0 0.64 19.10 0.3 1.5
    24 288.78 9.98 20.0 1.20 35.98 0.6 0.6
    48 176.08 122.68 20.0 1.77 53.20 0.9 0.5
    72 69.00 229.76 20.0 2.48 74.40 1.3 0.4
    #4 0 278.74 0.00 20.0 0.00 0.00
    5.5 279.47 0.00 20.0 0.7 21.00 0.4 1.6
    24 249.58 29.16 20.0 1.28 38.37 0.7 0.7
    48 130.63 148.11 20.0 2.00 58.89 1.1 0.5
    72 62.00 216.74 20.0 2.37 71.00 1.2 0.4
  • The average dissolving rate of each tablet is shown below:
    Formulation Average Dissolving Rate
    1 119
    2 74
    3 49
    4 58
  • While the invention has been described above with reference to specific embodiments thereof, it is apparent that many changes, modifications, and variations can be made without departing from the inventive concept disclosed herein. Accordingly, it is intended to embrace all such changes, modifications and variations that fall within the spirit and broad scope of the appended claims. All patent applications, patents and other publications cited herein are incorporated by reference in their entirety.

Claims (35)

  1. 1. A tablet comprising a homogeneous mixture of hydrated calcium hypochlorite with magnesium sulfate heptahydrate, wherein the mixture contains at least about 17% by weight of water based on the total weight of the mixture; wherein the average dissolving rate of the tablet is less than 150 grams per day; and wherein the tablet is a non-Division 5.1 Oxidizer.
  2. 2. The tablet of claim 1 wherein the mixture contains at least 25% by weight of magnesium sulfate heptahydrate and less than about 75% by weight of hydrated calcium hypochlorite.
  3. 3. The tablet of claim 1 wherein the mixture contains about 25% to about 40% by weight of magnesium sulfate heptahydrate and about 60% to about 75% of hydrated calcium hypochlorite.
  4. 4. The tablet of claim 1 wherein the amount of water in the mixture is from about 18% to about 24% by weight of the mixture.
  5. 5. The tablet of claim 1 wherein the average dissolving rate is less than about 100 grams per day.
  6. 6. A tablet consisting essentially of a homogeneous mixture of hydrated calcium hypochlorite with magnesium sulfate heptahydrate, wherein the blend contains at least 17% by weight of water based on the total weight of the mixture; wherein the average dissolving rate of the blend is less than 150 grams per day; and wherein the tablet is a non-Division 5.1 Oxidizer.
  7. 7. The tablet of claim 6 wherein the mixture contains at least 25% by weight of magnesium sulfate heptahydrate and less than about 75% by weight of hydrated calcium hypochlorite.
  8. 8. The tablet of claim 7 wherein the mixture contains about 25% to about 40% by weight of magnesium sulfate heptahydrate and about 60% to about 75% of hydrated calcium hypochlorite.
  9. 9. The tablet of claim 8 wherein the amount of water in the mixture is about 18% to about 24% by weight of the mixture.
  10. 10. The tablet of claim 9 wherein the average dissolving rate is less than 100 grams per day.
  11. 11. A non-Division 5.1 Oxidizer tablet consisting essentially of a blend containing hydrated calcium hypochlorite with magnesium sulfate heptahydrate, wherein the tablet contains at least 17% by weight water, based on the total weight of the blend; wherein the dissolving rate of the tablet is less than 150 grams per day.
  12. 12. The tablet of claim 11 wherein the blend contains at least 25% by weight of magnesium sulfate heptahydrate and less than about 75% by weight of hydrated calcium hypochlorite.
  13. 13. The tablet of claim 11 wherein the blend contains about 25% to about 40% by weight of magnesium sulfate heptahydrate and about 60% to about 75% of hydrated calcium hypochlorite.
  14. 14. The tablet of claim 11 wherein the amount of water in the blend is from about 18% to about 24% by weight of the tablet.
  15. 15. The tablet of claim 11 wherein the average dissolving rate is less than about 100 grams per day.
  16. 16. A tablet comprising a blend containing hydrated calcium hypochlorite with magnesium sulfate heptahydrate, wherein the tablet contains at least 17% by weight water, based on the total weight of the tablet; wherein the average dissolving rate of the tablet is less than 150 grams per day; and wherein the tablet is a non-Division 5.1 Oxidizer.
  17. 17. The tablet of claim 16 wherein the tablet contains at least 25% by weight of magnesium sulfate heptahydrate and less than about 75% by weight of hydrated calcium hypochlorite.
  18. 18. The tablet of claim 16 wherein the tablet contains about 25% to about 40% by weight of magnesium sulfate heptahydrate and about 60% to about 75% of hydrated calcium hypochlorite.
  19. 19. The tablet of claim 16 wherein the amount of water in the tablet is from about 18% to about 24% by weight of the tablet.
  20. 20. The tablet of claim 16 wherein the average dissolving rate is less than about 100 grams per day.
  21. 21. A tablet consisting essentially of a blend comprising hydrated calcium hypochlorite with magnesium sulfate heptahydrate, wherein the tablet contains at least 17% by weight water, based on the total weight of the tablet; wherein the average dissolving rate of the tablet is less than 150 grams per day; and the tablet is a non-Division 5.1 Oxidizer.
  22. 22. The tablet of claim 21 wherein the tablet contains at least 25% by weight of magnesium sulfate heptahydrate and less than about 75% by weight of hydrated calcium hypochlorite.
  23. 23. The tablet of claim 21 wherein the tablet contains about 25% to about 40% by weight of magnesium sulfate heptahydrate and about 60% to about 75% of hydrated calcium hypochlorite.
  24. 24. The tablet of claim 21 wherein the amount of water in the tablet is from about 18% to about 24% by weight of the tablet.
  25. 25. The tablet of claim 21 wherein the average dissolving rate is less than about 100 grams per day.
  26. 26. A tablet containing a blend comprising hydrated calcium hypochlorite with magnesium sulfate heptahydrate, wherein the tablet contains at least 17% by weight water, based on the total weight of the tablet; wherein the average dissolving rate of the tablet is less than 150 grams per day; and wherein the tablet is a non-Division 5.1 Oxidizer.
  27. 27. The tablet of claim 26 wherein the tablet contains at least 25% by weight of magnesium sulfate heptahydrate and less than about 75% by weight of hydrated calcium hypochlorite.
  28. 28. The tablet of claim 26 wherein the tablet contains about 25% to about 40% by weight of magnesium sulfate heptahydrate and about 60% to about 75% of hydrated calcium hypochlorite.
  29. 29. The tablet of claim 26 wherein the amount of water in the tablet is from about 18% to about 24% by weight of the tablet.
  30. 30. The tablet of claim 26 wherein the average dissolving rate is less than about 100 grams per day.
  31. 31. A tablet containing a blend consisting essentially of hydrated calcium hypochlorite with magnesium sulfate heptahydrate, wherein the tablet contains at least 17% by weight water, based on the total weight of the tablet; wherein the average dissolving rate of the tablet is less than 150 grams per day; and wherein the tablet is a non-Division 5.1 Oxidizer.
  32. 32. The tablet of claim 31 wherein the tablet contains at least 25% by weight of magnesium sulfate heptahydrate and less than about 75% by weight of hydrated calcium hypochlorite.
  33. 33. The tablet of claim 31 wherein the tablet contains about 25% to about 40% by weight of magnesium sulfate heptahydrate and about 60% to about 75% of hydrated calcium hypochlorite.
  34. 34. The tablet of claim 31 wherein the amount of water in the tablet is from about 18% to about 24% by weight of the tablet.
  35. 35. The tablet of claim 31 wherein the average dissolving rate is less than about 100 grams per day.
US11314512 2003-04-02 2005-12-21 Calcium hypochlorite blended tablets Abandoned US20060093669A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US10405388 US6984398B2 (en) 2003-04-02 2003-04-02 Calcium hypochlorite blended tablets
US11314512 US20060093669A1 (en) 2003-04-02 2005-12-21 Calcium hypochlorite blended tablets

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11314512 US20060093669A1 (en) 2003-04-02 2005-12-21 Calcium hypochlorite blended tablets

Publications (1)

Publication Number Publication Date
US20060093669A1 true true US20060093669A1 (en) 2006-05-04

Family

ID=33097084

Family Applications (3)

Application Number Title Priority Date Filing Date
US10405388 Active US6984398B2 (en) 2003-04-02 2003-04-02 Calcium hypochlorite blended tablets
US10783210 Active US6969527B2 (en) 2003-04-02 2004-02-20 Calcium hypochlorite blended tablets
US11314512 Abandoned US20060093669A1 (en) 2003-04-02 2005-12-21 Calcium hypochlorite blended tablets

Family Applications Before (2)

Application Number Title Priority Date Filing Date
US10405388 Active US6984398B2 (en) 2003-04-02 2003-04-02 Calcium hypochlorite blended tablets
US10783210 Active US6969527B2 (en) 2003-04-02 2004-02-20 Calcium hypochlorite blended tablets

Country Status (4)

Country Link
US (3) US6984398B2 (en)
CN (1) CN100522136C (en)
DE (1) DE602004029526D1 (en)
ES (1) ES2354042T3 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070125979A1 (en) * 2005-12-01 2007-06-07 Deqing Lei Coated calcium hypochlorite composition
US20070210280A1 (en) * 2006-03-08 2007-09-13 Pickens Stanley R Calcium hypochlorite composition
US8647567B2 (en) 2011-04-06 2014-02-11 The Clorox Company Methods of providing uniform delivery of a functional agent from a shaped composition

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6984398B2 (en) * 2003-04-02 2006-01-10 Arch Chemicals, Inc. Calcium hypochlorite blended tablets
CA2520857C (en) * 2003-04-02 2011-09-20 Arch Chemicals, Inc. Calcium hypochlorite blended tablets
US7045077B2 (en) * 2004-06-18 2006-05-16 Biolab, Inc. Calcium hypochlorite compositions
US7820198B2 (en) * 2004-10-19 2010-10-26 Arch Chemicals, Inc. Pool chemical tablet
US7758709B2 (en) 2006-06-21 2010-07-20 Autoliv Asp, Inc. Monolithic gas generant grains
US7625496B2 (en) 2006-11-03 2009-12-01 Chemtura Corporation Solid composition for treating water
US9193639B2 (en) 2007-03-27 2015-11-24 Autoliv Asp, Inc. Methods of manufacturing monolithic generant grains
US7927510B2 (en) * 2007-04-20 2011-04-19 Arch Chemicals, Inc. Calcium hypochlorite compositions comprising zinc salts and lime
US8372291B2 (en) * 2007-04-20 2013-02-12 Arch Chemicals, Inc. Calcium hypochlorite compositions comprising zinc salts and lime
US8057611B2 (en) * 2007-08-13 2011-11-15 Autoliv Asp, Inc. Multi-composition pyrotechnic grain
US8815029B2 (en) * 2008-04-10 2014-08-26 Autoliv Asp, Inc. High performance gas generating compositions
US8808476B2 (en) * 2008-11-12 2014-08-19 Autoliv Asp, Inc. Gas generating compositions having glass fibers
US8361945B2 (en) * 2008-12-09 2013-01-29 The Clorox Company Solid-layered bleach compositions and methods of use
US8361942B2 (en) * 2008-12-09 2013-01-29 The Clorox Company Hypochlorite denture compositions and methods of use
US8287755B2 (en) 2008-12-09 2012-10-16 The Clorox Company Solid-layered bleach compositions
US8361944B2 (en) * 2008-12-09 2013-01-29 The Clorox Company Solid-layered bleach compositions and methods of use
US9051223B2 (en) 2013-03-15 2015-06-09 Autoliv Asp, Inc. Generant grain assembly formed of multiple symmetric pieces
EP3294678A1 (en) 2015-05-14 2018-03-21 Arch Chemicals, Inc. Slow dissolving hypochlorite containing tablet

Citations (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3668134A (en) * 1968-09-27 1972-06-06 Lever Brothers Ltd Detergent compositions containing the ethers and esters of tetrahydrofuran and tetrahydropyran
US3669891A (en) * 1969-05-30 1972-06-13 Lever Brothers Ltd Chemical compositions
US3669546A (en) * 1969-10-28 1972-06-13 Instr De Controle Et D Analyse Device for spectrographic analysis of a liquid metal
US3793216A (en) * 1971-12-06 1974-02-19 Pennwalt Corp Calcium hypochlorite composition
US3969546A (en) * 1974-11-06 1976-07-13 Olin Corporation Process for preparing granular calcium hypochlorite in a fluidized bed
US4005028A (en) * 1975-04-22 1977-01-25 The Procter & Gamble Company Organosilane-containing detergent composition
US4048351A (en) * 1974-11-06 1977-09-13 Olin Corporation Granular calcium hypochlorite coated with a low melting inorganic salt by spray graining
US4051056A (en) * 1974-09-09 1977-09-27 The Procter & Gamble Company Abrasive scouring compositions
US4071605A (en) * 1977-01-31 1978-01-31 Olin Corporation Process for the production of dibasic magnesium hypochlorite
US4118524A (en) * 1972-07-31 1978-10-03 Olin Corporation Granular calcium hypochlorite by spray graining
US4145306A (en) * 1976-03-25 1979-03-20 Nippon Soda Company Limited Calcium hypochlorite composition
US4146676A (en) * 1975-03-12 1979-03-27 Olin Corporation Granular calcium hypochlorite coated with a low melting inorganic salt by spray graining
US4174411A (en) * 1972-07-31 1979-11-13 Olin Corporation Granular calcium hypochlorite coated with an inorganic salt by spray graining
US4192763A (en) * 1977-02-16 1980-03-11 Buchan P W W Chlorine tablet and the preparation thereof
US4201756A (en) * 1972-07-31 1980-05-06 Olin Corporation Granular calcium hypochlorite coated with an inorganic salt
US4208756A (en) * 1978-07-31 1980-06-24 Smith Samuel C Chimney cleaner
US4216027A (en) * 1978-04-18 1980-08-05 The Procter & Gamble Company Method and apparatus for cleansing and disinfecting a flushing toilet
US4289640A (en) * 1974-01-21 1981-09-15 Colgate-Palmolive Company Cleaning compositions
US4355014A (en) * 1979-05-29 1982-10-19 Toyo Soda Manufacturing Co., Ltd. Stable calcium hypochlorite composition and method for manufacture thereof
US4380533A (en) * 1980-03-12 1983-04-19 Olin Corporation Process for the production of dibasic magnesium hypochlorite
US4539179A (en) * 1982-04-02 1985-09-03 Twinoak Products, Inc. Method for cleansing and disinfecting toilet tanks and bowls
US4615794A (en) * 1984-08-20 1986-10-07 Belanger Roger L Method of removing radioactive waste from oil
US4668475A (en) * 1982-04-02 1987-05-26 Twinoak Products, Inc. Cleaning and disinfecting method and article of manufacture including color display
US4692335A (en) * 1985-09-03 1987-09-08 Ppg Industries, Inc. Calcium hypochlorite tablet
US4863709A (en) * 1986-11-18 1989-09-05 Tosoh Corporation Calcium hypochlorite composition and process for preparation thereof
US4865760A (en) * 1988-04-06 1989-09-12 Ppg Industries, Inc. Calcium hypochlorite composition
US4876003A (en) * 1988-05-09 1989-10-24 Olin Corporation Encased pool chemical tablet with domed ends
US4928813A (en) * 1989-06-02 1990-05-29 Olin Corporation Encased pool chemical capsule with extended ends and method of making the same
US4931207A (en) * 1984-01-27 1990-06-05 The Clorox Company Bleaching and bluing composition and method
US4961872A (en) * 1987-10-26 1990-10-09 The Drackett Company Calcium hypochlorite tablets
US4970020A (en) * 1988-04-06 1990-11-13 Ppg Industries, Inc. Calcium hypochlorite composition
US5009806A (en) * 1988-04-06 1991-04-23 Ppg Industries, Inc. Calcium hypochlorite article
US5164109A (en) * 1990-05-31 1992-11-17 Olin Corporation Algicidally enhanced calcium hypochlorite compositions
US5205961A (en) * 1991-04-18 1993-04-27 Ppg Industries, Inc. Granular calcium hypochlorite treatment process
US5610126A (en) * 1985-06-14 1997-03-11 Jeyes Group Limited Lavatory cleansing compositions
US5707534A (en) * 1995-07-10 1998-01-13 Buckman Laboratories International, Inc. Use of tabletized ionene polymers in water treatment
US5753602A (en) * 1995-12-18 1998-05-19 The Block Drug Company Chlorine cleanser tabletting process and product
US5756440A (en) * 1997-05-27 1998-05-26 The Clorox Company Solid, water-degradable disinfectant and cleanser composition, and associated methods of manufacture and use
US5763302A (en) * 1995-06-07 1998-06-09 Lsi Logic Corporation Self-aligned twin well process
US5888528A (en) * 1997-05-19 1999-03-30 Bernard Technologies, Inc. Sustained release biocidal powders
US5914040A (en) * 1994-02-01 1999-06-22 Rhone-Poulenc Chimie Process for the purification of a medium containing organic waste
US6638446B1 (en) * 2002-10-15 2003-10-28 Arch Chemicals, Inc. Lower reactivity blends of calcium hypochlorite and magnesium sulfate
US6969527B2 (en) * 2003-04-02 2005-11-29 Arch Chemicals, Inc. Calcium hypochlorite blended tablets
US20050279971A1 (en) * 2004-06-18 2005-12-22 Garris John P Calcium hypochlorite compositions

Patent Citations (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3668134A (en) * 1968-09-27 1972-06-06 Lever Brothers Ltd Detergent compositions containing the ethers and esters of tetrahydrofuran and tetrahydropyran
US3669891A (en) * 1969-05-30 1972-06-13 Lever Brothers Ltd Chemical compositions
US3669546A (en) * 1969-10-28 1972-06-13 Instr De Controle Et D Analyse Device for spectrographic analysis of a liquid metal
US3793216A (en) * 1971-12-06 1974-02-19 Pennwalt Corp Calcium hypochlorite composition
US4174411A (en) * 1972-07-31 1979-11-13 Olin Corporation Granular calcium hypochlorite coated with an inorganic salt by spray graining
US4201756A (en) * 1972-07-31 1980-05-06 Olin Corporation Granular calcium hypochlorite coated with an inorganic salt
US4118524A (en) * 1972-07-31 1978-10-03 Olin Corporation Granular calcium hypochlorite by spray graining
US4289640A (en) * 1974-01-21 1981-09-15 Colgate-Palmolive Company Cleaning compositions
US4051056A (en) * 1974-09-09 1977-09-27 The Procter & Gamble Company Abrasive scouring compositions
US4048351A (en) * 1974-11-06 1977-09-13 Olin Corporation Granular calcium hypochlorite coated with a low melting inorganic salt by spray graining
US3969546A (en) * 1974-11-06 1976-07-13 Olin Corporation Process for preparing granular calcium hypochlorite in a fluidized bed
US4146676A (en) * 1975-03-12 1979-03-27 Olin Corporation Granular calcium hypochlorite coated with a low melting inorganic salt by spray graining
US4005028A (en) * 1975-04-22 1977-01-25 The Procter & Gamble Company Organosilane-containing detergent composition
US4145306A (en) * 1976-03-25 1979-03-20 Nippon Soda Company Limited Calcium hypochlorite composition
US4071605A (en) * 1977-01-31 1978-01-31 Olin Corporation Process for the production of dibasic magnesium hypochlorite
US4192763A (en) * 1977-02-16 1980-03-11 Buchan P W W Chlorine tablet and the preparation thereof
US4216027A (en) * 1978-04-18 1980-08-05 The Procter & Gamble Company Method and apparatus for cleansing and disinfecting a flushing toilet
US4208756A (en) * 1978-07-31 1980-06-24 Smith Samuel C Chimney cleaner
US4355014A (en) * 1979-05-29 1982-10-19 Toyo Soda Manufacturing Co., Ltd. Stable calcium hypochlorite composition and method for manufacture thereof
US4380533A (en) * 1980-03-12 1983-04-19 Olin Corporation Process for the production of dibasic magnesium hypochlorite
US4539179A (en) * 1982-04-02 1985-09-03 Twinoak Products, Inc. Method for cleansing and disinfecting toilet tanks and bowls
US4668475A (en) * 1982-04-02 1987-05-26 Twinoak Products, Inc. Cleaning and disinfecting method and article of manufacture including color display
US4931207A (en) * 1984-01-27 1990-06-05 The Clorox Company Bleaching and bluing composition and method
US4615794A (en) * 1984-08-20 1986-10-07 Belanger Roger L Method of removing radioactive waste from oil
US5610126A (en) * 1985-06-14 1997-03-11 Jeyes Group Limited Lavatory cleansing compositions
US4692335A (en) * 1985-09-03 1987-09-08 Ppg Industries, Inc. Calcium hypochlorite tablet
US4863709A (en) * 1986-11-18 1989-09-05 Tosoh Corporation Calcium hypochlorite composition and process for preparation thereof
US4961872A (en) * 1987-10-26 1990-10-09 The Drackett Company Calcium hypochlorite tablets
US4865760A (en) * 1988-04-06 1989-09-12 Ppg Industries, Inc. Calcium hypochlorite composition
US4970020A (en) * 1988-04-06 1990-11-13 Ppg Industries, Inc. Calcium hypochlorite composition
US5009806A (en) * 1988-04-06 1991-04-23 Ppg Industries, Inc. Calcium hypochlorite article
US4876003A (en) * 1988-05-09 1989-10-24 Olin Corporation Encased pool chemical tablet with domed ends
US4928813A (en) * 1989-06-02 1990-05-29 Olin Corporation Encased pool chemical capsule with extended ends and method of making the same
US5164109A (en) * 1990-05-31 1992-11-17 Olin Corporation Algicidally enhanced calcium hypochlorite compositions
US5205961A (en) * 1991-04-18 1993-04-27 Ppg Industries, Inc. Granular calcium hypochlorite treatment process
US5914040A (en) * 1994-02-01 1999-06-22 Rhone-Poulenc Chimie Process for the purification of a medium containing organic waste
US5763302A (en) * 1995-06-07 1998-06-09 Lsi Logic Corporation Self-aligned twin well process
US5707534A (en) * 1995-07-10 1998-01-13 Buckman Laboratories International, Inc. Use of tabletized ionene polymers in water treatment
US5753602A (en) * 1995-12-18 1998-05-19 The Block Drug Company Chlorine cleanser tabletting process and product
US5888528A (en) * 1997-05-19 1999-03-30 Bernard Technologies, Inc. Sustained release biocidal powders
US5756440A (en) * 1997-05-27 1998-05-26 The Clorox Company Solid, water-degradable disinfectant and cleanser composition, and associated methods of manufacture and use
US5958853A (en) * 1997-05-27 1999-09-28 The Clorox Company Solid, water-degradable disinfectant and cleanser composition, and associated methods of manufacture and use
US6638446B1 (en) * 2002-10-15 2003-10-28 Arch Chemicals, Inc. Lower reactivity blends of calcium hypochlorite and magnesium sulfate
US6969527B2 (en) * 2003-04-02 2005-11-29 Arch Chemicals, Inc. Calcium hypochlorite blended tablets
US6984398B2 (en) * 2003-04-02 2006-01-10 Arch Chemicals, Inc. Calcium hypochlorite blended tablets
US20050279971A1 (en) * 2004-06-18 2005-12-22 Garris John P Calcium hypochlorite compositions
US7045077B2 (en) * 2004-06-18 2006-05-16 Biolab, Inc. Calcium hypochlorite compositions

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070125979A1 (en) * 2005-12-01 2007-06-07 Deqing Lei Coated calcium hypochlorite composition
US8252200B2 (en) * 2005-12-01 2012-08-28 Arch Chemicals, Inc. Coated calcium hypochlorite composition
US20070210280A1 (en) * 2006-03-08 2007-09-13 Pickens Stanley R Calcium hypochlorite composition
US7431863B2 (en) * 2006-03-08 2008-10-07 Ppg Industries Ohio, Inc. Calcium hypochlorite composition
US8647567B2 (en) 2011-04-06 2014-02-11 The Clorox Company Methods of providing uniform delivery of a functional agent from a shaped composition
US8920743B2 (en) 2011-04-06 2014-12-30 The Clorox Company Faucet mountable water conditioning devices
US8955536B2 (en) 2011-04-06 2015-02-17 The Clorox Company Faucet mountable water conditioning systems

Also Published As

Publication number Publication date Type
ES2354042T3 (en) 2011-03-09 grant
US20040214738A1 (en) 2004-10-28 application
US6969527B2 (en) 2005-11-29 grant
DE602004029526D1 (en) 2010-11-25 grant
CN100522136C (en) 2009-08-05 grant
US6984398B2 (en) 2006-01-10 grant
US20040197395A1 (en) 2004-10-07 application
CN1767813A (en) 2006-05-03 application

Similar Documents

Publication Publication Date Title
US3152073A (en) Method for the sterilization of water
US7229647B2 (en) Chlorine dioxide gel and associated methods
US5958979A (en) Stabilized medicaments containing thyroid hormones
US4931202A (en) Detergent pellet composition and process therefor
US5763376A (en) Lavatory cleaning block
US6299909B1 (en) Concentrated aqueous bromine solutions and their preparation
US6680070B1 (en) Particulate blends and compacted products formed therefrom, and the preparation thereof
US5338461A (en) Method of disinfecting a water system with a dry oxidizer composition
US4355014A (en) Stable calcium hypochlorite composition and method for manufacture thereof
US4547381A (en) Dry compositions for the production of chlorine dioxide
US4401665A (en) Sleep-aid composition containing an analgesic and diphenhydramine dihydrogencitrate, and method of use
US5753602A (en) Chlorine cleanser tabletting process and product
US4668475A (en) Cleaning and disinfecting method and article of manufacture including color display
US4689169A (en) Dry compositions for the production of chlorine dioxide
US5021186A (en) Chloroisocyanuric acid composition having storage stability
US7534368B2 (en) Oxidizing composition including a gel layer
US5565576A (en) Halohydantoin and fatty amide composition for compaction, process of compacting and product produced thereby
US5498415A (en) Disinfectant for the treatment of water systems
US5178787A (en) Lavatory cleaning block comprising n,n-dichloro dialkyl hydantoin and aluminum hydroxide
US4389318A (en) Rapidly dissolving mixtures containing trichloroisocyanuric acid
US6727219B2 (en) Single dosage oxidizing treatment
US5514287A (en) Method and compositions for treating recirculating water systems
US20060169949A1 (en) Massive bodies containing free halogen source for producing highly converted thickened solutions of chlorine dioxide
US4661157A (en) Production of shaped bodies of boron compounds
US5407598A (en) Shaped solid bleach with encapsulate source of bleach